Pheochromocytoma--the catecholamine dependent hypertension

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Oncology

Background:

• Pheochromocytoma is a rare endocrine tumor causing hypertension through excessive catecholamine production.
• It affects 0.1-0.8% of hypertensive patients and can be life-threatening.
• Understanding its varied hormonal activity is key to managing blood pressure and symptoms.

Purpose of the Study:

• To review the diagnosis and treatment of pheochromocytoma based on institutional experience.
• To highlight advancements in diagnostic methods over three decades.
• To emphasize surgical resection as the primary therapeutic approach.

Main Methods:

• Review of 138 patients treated for pheochromocytoma between 1956 and 1995.
• Analysis of clinical presentation, hormonal activity, and diagnostic approaches.
• Evaluation of treatment outcomes, focusing on surgical intervention.

Main Results:

• Pheochromocytoma presents with variable blood pressure patterns and clinical symptoms due to diverse hormonal activity.
• Biochemical tests and non-invasive imaging have significantly improved diagnostic accuracy.
• Surgical removal of the tumor was the definitive treatment, achieving low morbidity and mortality.

Conclusions:

• Pheochromocytoma diagnosis relies on integrated biochemical and imaging techniques.
• Effective management involves recognizing diverse pathophysiological mechanisms.
• Surgical excision remains the gold standard for treating pheochromocytoma, offering excellent outcomes.